INTERNATIONAL PATENT: ONCTERNAL THERAPEUTICS, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FILES APPLICATION FOR "GLYCOENGINEERED FORMS OF ROR1 ANTIBODIES AND METHODS OF USE"

GENEVA, Feb. 12 -- ONCTERNAL THERAPEUTICS, INC. (12230 El Camino Real, Suite 230San Diego, California 92130), THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1111 Franklin Avenue, 12th FloorOakland, California 94607) filed a patent application (PCT/US2024/040391) for "GLYCOENGINEERED FORMS OF ROR1 ANTIBODIES AND METHODS OF USE" on Jul 31, 2024. With publication no. WO/2025/029920, the details related to the patent application was published on Feb 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIPPS, Thomas J. (1111 Franklin Avenue, 12th FloorOakland, California 94607), WIDHOPF, II, George ...